Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 4c

Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q2 EPS of ($0.36), $0.04 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.

You May Also Be Interested In

• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• The Children's Place (PLCE) PT Lowered to $3.25 at UBS on Soft Sales Trends
• United Community Banks (UCB) PT Raised to $42 at DA Davidson